Abstract
The European Journal of Obstetrics and Gynaecology and Reproductive Biology considers itself to be the forum for clinical and basic scientists in our specialty in Europe. In this context we would like you to be aware of a European organisation where you can find support for your research: the European Science Foundation (www.esf.org) promotes high quality science at a European level. It acts as a catalyst by bringing together leading scientists and funding agencies to debate, plan and implement pan-European initiatives. The Medical Sciences cover such fields as immunology, human genetics and functional genomics, biotechnology, diagnostic and therapeutic medicine, communicable diseases, clinical studies and public health. The Standing Committee, the European Medical Research Council (EMRC), has the overall responsibility for initiating and coordinating scientific activities in those fields and for providing expert advice on issues of science policy. A number of publications are available, which give an insight into activities on the European level. One of the European Clinical Trials has been the investigation “Thromboprophylaxis Using Low molecular weight heparin In Pregnancy (TULIP)”. Activities and results are outlined in detail on the internet. Another group of researchers under the chairmanship of Dr Jacques Sizun came together to conduct “Research on Early Developmental Care for Extremely Premature Babies in Neonatal Intensive Care Units (ECD)”.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: European Journal of Obstetrics & Gynecology and Reproductive Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.